The proportion of the enzyme present in the active dephosphorylated form is decreased by starvation and diabetes in heart and kidney and starvation in liver and this may be related to the increased utilization of lipid fuels in these conditions (Wieland, Siess, Schulze-Wethmar, von Funke & Winton, 1971; Wieland et al., 1973; Kerbey et al., 1976) .
In adipose tissue, where the enzyme serves a largely biosynthetic role in fatty acid production, insulin markedly increases the proportion of the complex in the active form both in vivo and in vitro; adrenaline opposes this effect. Conditions which result in low plasma insulin levels, namely alloxan diabetes and starvation, decrease the proportion in the active form whereas long-term fat-feeding results in a repression of total enzyme activity (Coore, Denton, Martin & Randle, 1971; Jungas, 1971; Weiss, Loffler, Schirmann & Wieland, 1971; Stansbie, Denton & Randle, 1975; Stansbie, Denton, Bridges, Pask & Randle, 1976) .
The regulation of pyruvate dehydrogenase activity in human tissues hasreceivedlittleattention, although it is known to be largely responsible for the control of fatty acid synthesis de novo in the rat and could be involved in the pathogenesis of obesity and the hyperlipidaemias. Alloxan diabetes in animals results in impaired sensitivity of the enzyme to insulin in adipose tissue and also to a decreased stimulation of activity in hearts perfused with medium containing pyruvate, but the relevance of these findings to the metabolism of diabetic patients is not clear. Descriptions of a possible inborn error of metabolism associated with decreased pyruvate oxidation (Blass, Schulman, Young & Hom, 1972) have also raised the possibility that metabolic abnormalities of the pyruvate dehydrogenase complex could be associated with various diseases. These findings have prompted an investigation of some of the regulatory features of the human enzyme complex and development of techniques for studying these in small biopsy samples. The aim has been to establish that the regulatory features of the human complex were essentially similar to those of other mammalian species studied.
Materials and methods

Soiirce of tissue
All of the studies described in this paper were carried out with the approval and permission of the Bristol Royal Infirmary ethical committee. Myocardium was obtained post mortem from a 20-yearold female who died from barbiturate poisoning; skeletal muscle was donated by a 51-year-old male undergoing a lower limb amputation; omental adipose tissue was given by patients undergoing elective surgery (cholecystectomy, partial gastrectomy or large bowel resection). Lipomata were obtained after removal under local anaesthesia, care being taken to ensure that the tissue used had not been infiltrated by the anaesthetic, and small samples of liver (5 mg) were obtained after needle biopsy for diagnostic purposes. All of the tissue samples were plunged into liquid Nz within 2 min of removal, except the myocardium which was kept in ice. Specimens of omental adipose tissue, liver, skeletal muscle and kidney were also obtained post mortem from patients known to have been free from metabolic diseases including diabetes mellitus,
Biochemicals
Biochemicals were purchased from Boehringer Corp. (London) Ltd (London, W.5); pyruvate dehydrogenase phosphate phosphatase was prepared from pig heart as described by Severson et al. (1974) .
Pig heart pyruvate dehydrogenase phosphate (17 unitslml when fully active and containing negligible amounts of pyruvate dehydrogenase phosphate phosphatase) was a gift from Dr R. H. Cooper, Biochemistry Department, University of Bristol.
Human heart pyruvate dehydrogenase and pyruvate dehydrogenase phosphate phosphatase These were partially purified by a procedure based upon the method used by to obtain rat heart pyruvate dehydrogenase. Myocardium (130 g) was chopped with scissors and extracted in 300 ml of potassium phosphate buffer (30 mmol/l), pH 7.0, containing MgClz (2 mmol/l) and mercaptoethanol (1 mmol/l) at 4°C with a Polytron PTlO tissue homogenizer. The extract was centrifuged at 30000 g for 30 min at 4°C and the supernatant treated with solid (NH,),S04 (209 g/l), care being taken to maintain the pH at 7.0. After centrifugation at 15 OOO g the pellet was redissolved in 5 ml of 20 mmol/l potassium phosphate buffer, pH 7.0, containing mercaptoethanol (5 mmol/l) and dialysed overnight against 200 vol. of thesame buffer. The solution was centrifuged at 30 OOO g for 30 min at 4°C and the supernatant adjusted to pH 6.1 with acetic acid (1.75 mol/l). The precipitate was discarded and the supernatant readjusted to pH 7.0 and stored at -20°C. At this stage the solution contained pyruvate dehydrogenase and its loosely bound phosphatase (both enzymes are stable in this form for 2-3 weeks). Before each experiment pyruvate dehydrogenase was separated from its contaminating phosphatase by centrifuging the mixture at 150 000 g and 4°C for 90 min. The pellet obtained in this way consisted of partially purified (90-fold) pyruvate dehydrogenase essentially free of phosphatase activity; in contrast the supernatant consisted of pyruvate dehydrogenase phosphate phosphatase containing neglible amounts of pyruvate dehydrogenase. The yield of pyruvate dehydrogenase was about 5%.
Assay of pyruvate dehydrogenase activity in extracts of adipose tissue, liver, skeletal muscle, kidney and heart Samples of kidney, heart and adipose tissue from omentum or lipomata were extracted at 0°C with potassium phosphate (100 mmol/l), EDTA (2 or 5 mmol/l) buffer, pH 7.0, containing mercaptoethanol (5 mmolll) in a Polytron PT-10 tissue homogenizer; muscle was extracted in the same way except that the potassium phosphate concentration was 20 mmol/l. Small fragments of liver were ground in a Kontes tissue grinder in potassium phosphate buffer (100 mmol/l), pH 7.0, containing EDTA (2 mmol/l). Initial pyruvate dehydrogenase activity was assayed by the method given by Martin, Denton, Pask & Randle (1972) ; it was assumed that prompt freezing of tissues in liquid NZ followed by extraction in an EDTA-containing buffer assured that the activity assayed in the extracts accurately reflected the proportion of the enzyme in its active form in vivo. Total pyruvate dehydrogenase activity was assayed after incubation of the extract with pig heart pyruvate dehydrogenase phosphate phosphatase, MgCL (25 mmol/l) and CaCL (1-2 mmol/l) for 10-15 min at 30°C.
Incorporation of [32Plphosphate from [Y-~'P]ATP into pyruvate dehydrogenase
This was studied with a method based upon that described by for the assay of pyruvate dehydrogenase kinase. Pyruvate dehydro- 
Requirements of human heart pyruvate dehydrogenase phosphate phosphatase for Mgz+ and Ca2+
Pig heart pyruvate dehydrogenase phosphate (20 munits) was incubated with human heart phosphatase (32.5-40 pl in a total volume of 50 PI), and the concentrations of EGTA [ethanedioxybis(ethylamine)tetra-acetate], MgClz and CaCL indicated in Fig. 2 , at 30°C for 15 min. Samples (5 pl) were removed at the times indicated and pyruvate dehydrogenase activity was assayed. The incubation was also performed in the presence of pig heart pyruvate dehydrogenase phosphate phosphatase (200 munits), MgClz (25 mmol/l) and CaClz (1 mmol/l). Under these conditions the pyruvate dehydrogenase was fully active after 2 min incubation and did not increase after a further 8 min. The activity of pyruvate dehydrogenase measured under these conditions was taken to be maximum.
The calculations of Ca2+ and Mg2+ concentrations in the presence of EGTA and phosphate were computed as detailed in Severson et al. (1974) .
The activation of human skeletal muscle pyruvate dehydrogenase by its endogenous phosphatase was carried out in a crude tissue extract. All incubations were performed at 30°C under the conditions described in the text or legend to Table 2 .
Enzyme activities are given as units of activity (1 pmol of substrate converted/min = 1 unit', measured at 30°C.
Protein assay of tissue extracts was performed by the method of Lowry, Rosebrough, Farr & Randall (1951) with bovine serum albumin used as standard.
Results and discussion
Inactivation by phosphorylation of human heart pyruvate dehydrogenase activity of pyruvate dehydrogenase was associated with the incorporation of 32P into the protein, and the time-course of the reaction indicates that phosphorylation and inactivation occurred simultaneously. The concentration of Mg2--ATP (2 mmol/l) necessary for these experiments was rather higher than that used by other workers (approx 0-2 mmolll) because the relatively impure pyruvate dehydrogenase preparation contained considerable adenosine triphosphatase activity (Linn et al., 1969a, b; Wieland & Jagow-Westermann, 1969; Coore et at., 1971 ). Further purification was not possible because of the limited quantity of material available and the large losses sustained when attempting to purify the enzyme from post-mortem tissue.
The inactivation of human pyruvate dehydrogenase by ATP was partially prevented by pyruvate, ADP, TPP and dichloroacetate. The results reported in Table 1 are from an experiment with the same batch of human enzyme and show that the decrease in activity after incubation with ATP for 5 min was reduced from 60% to approximately 30% by pyruvate, ADP, TPP and dichloroacetate. These compounds are probably exerting their effects via inhibition of pyruvate dehydrogenase kinase. The activity of pyruvate dehydrogenase incubated at 30°C with no additions also declined slowly, and a similar problem was experienced by Coore & Field (1974) with the rat mammary gland enzyme. The reasons for this are not understood.
It was not possible to study the activation of pyruvate dehydrogenase kinase by increased ratios of NADH/NAD+ and acetyl-CoA/CoA as described by Cooper et al. (1975) and Pettit et al. (1975) for other mammalian tissues since this requires an enzyme preparation free of NADH oxidase and acetyl-CoA deacylase activity.
Activation of pig heart pyruvate dehydrogeiiase phosphate by human heart phosphatase
The Mg2+ and Ca2+ requirements of human heart pyruvate dehydrogenase phosphate phosphatase are shown in Fig. 2 . The increase in activity of pig heart pyruvate dehydrogenase was measured after incubation of the inactive phosphorylated form with human phosphatase and different concentrations of Mg2+ and Caz+. In the absence of Mgz+ and Ca2 + human phosphatase was incapable of activating the pig heart enzyme; however, the addi- 
FIG. 2. Activation of pig heart pyruvate dehydrogenase
phosphate by human heart pyruvate dehydrogenase phosphate phosphatase, and the effects of various MgZ+ and Caf+ concentrations. The inactive pig heart enzyme was incubated in potassium phosphate buffer (20 mmol/l), pH 7.0, at 30°C with human heart phosphatase and: MgCl, (25 mmol/l), CaCI2 (1 mmol/l), giving 10.2 mmol/l MgZ+, 056 mmol/l CaZ+ (m); EGTA (10 mmol/l), MgCI, (6.25 mmol/l), CaCl, (9.75 mmol/l), giving 1.13 mmol/l Mg2+, 7.20 pmol/l Ca2+ (A); EGTA (10 mmol/l), MgCl, (6.25 mmol/l), giving 1.04 mmol/l Mgz+ (0). The results are single observations on the same batch of human phosphatase and are expressed as the percentage increment in activity that was measured after incubation of the pyruvate dehydrogenase phosphate with MgClz (25 mmol/l), .CaCl2 (1 mmol/l) and 200 munits of pig heart phosphatase. Under these conditions all of the inactive enzyme was dephosphorylated within 2 min. No activation was observed when the incubation was performed with human heart phosphatase in the absence of MgC1, and CaCI,. and 0.56 mmol/l Ca2+ resulted in the complete conversion of pig heart pyruvate dehydrogenase into the active form after 15 min incubation.
The calcium sensitivity of human phosphatase was investigated by comparing its activity in the presence of Mg2+ (approximately 1 mmol/l) either with no free Caz+ or with 7.2 pmol/l Ca2+. In the absence of Cat+ virtually no phosphatase activity was detectable but in contrast Caz+ at 7.2 pmol/l is almost as effective as 0.56 mmol/l Ca2+ in stimulating phosphatase activity. The requirements for Mg"+ and the sensitivity to very small concentrations of free Cat+ are characteristic features of many of the pyruvate dehydrogenase phosphatases studied to date and confums the similarity between human and other mammalian enzymes (Linn et al., 1969a, b; Wieland & Siess, 1970; Denton et al., 1972) .
Activation studies on human skeletal muscle pyruvate dehydrogenase
The proportion of pyruvate dehydrogenase present in its active form is known to be decreased by starvation and consequently activation studies can be performed on crude extracts of tissues removed from starved patients. Table 2 shows the results of an experiment in which an extract of human skeletal muscle was assayed for pyruvate dehydrogenase TABLE 2. Effects of Mg2+ and Ca2+ on the activation of human skeletal muscle pyruuate dehydrogenase Skeletal muscle (1 g from the leg of a 12 h fasted, anaesthetized patient) was collected into liquid N2 and extracted at O°C in potassium phosphate buffer (20 mmol/l), pH 7.0, containing mercaptoethanol (5 mmol/l) and EDTA (2 mmol/l). Muscle extract (50~1) was incubated at 3OoC in potassium phosphate buffer (20 mmol/l), pH 7.0, containing EDTA (2 mmol/l) and sodium pyruvate (10 mmol/l) with the indicated additions in a total volume of 75p1.
Results are single observations from the same muscle extract. 
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(n = 1 ) activity after incubation with various concentrations of Mg2+ and Ca2+. The enzyme was converted into its active form by incubating the tissue extract in the presence of pig heart phosphatase, MgC12 (20 mmol/l) and CaC12 (2 mmol/l), which resulted in a fourfold increase in activity after 5 min incubation (this was assumed to be the total activity). The crude extract was also incubated in the presence of various Caz+ and Mgz+ concentrations as specified in the legend to Table 2 , but in these experiments no exogenous phosphatase was added; the increase in activity seen was due to the conversion of phosphorylated muscle pyruvate dehydrogenase into its active dephospho form by endogenous muscle phosphatase. An interpretation of this experiment is that human muscle pyruvate dehydrogenase exists in active and inactive forms, and that Mgz+ and Ca2+ are required for facilitation of the activation step. As in the experiments with human heart phosphatase, small concentrations of Ca2+ were effective in stimulating the activation presumably due to their effects on pyruvate dehydrogenase phosphatase. Although there are practical problems in studying pyruvate dehydrogenase activation by this technique it offers a means of studying pyruvate dehydrogenase and its phosphatase in small (100-150 mg) biopsy samples from patients.
Activity of pyruvate dehydrogenase in human adipose tissue, liver, skeletal muscle, heart and kidney Table 3 shows the results of a survey of pyruvate dehydrogenase activity in various fresh and postmortem human tissues. It was possible to measure an increase in the activity of the enzyme from fresh omentum, lipoma, liver and skeletal muscle by incubating the tissue extract with pig heart phosphatase, MgCI2 and CaCI2 as described in the Materials and Methods section. It was not possible to activate pyruvate dehydrogenase in post-mortem tissues or in a sample of cooled non-beating heart obtained during surgery. However, since the total activity of pyruvate dehydrogenase in the fresh or post-mortem tissues studied was very similar, it seems likely that in the post-mortem tissues and the sample of fresh heart all of the enzyme present was in the active form. This is to be expected since ATP is required to maintain the enzyme in its inactive state and its intracellular concentration falls after tissue death or during prolonged anoxia.
The total activity of the enzyme is also of interest, so human values were compared with those found in the rat. The total pyruvate dehydrogenase activity found in 200 g Wistar rats fed on a largely carbohydrate diet (modified diet 41B: Oxoid Ltd, London, S.E.l) are as follows (results are in terms of nmol of substrate transformed min-' g-' wet wt. and are typical values): adipose tissue, 400; heart, 5000; skeletal muscle, 1200; kidney, 2000; liver, 1200. Despite the wide scatter of the human results, the mean total activity in heart, skeletal muscle, kidney and liver is very close in each case to 25% of the rat values; in contrast, however, the activity in human adipose tissue is less than 10% of the rat value. These results are in agreement with the work of Weiss, Kreisel, Haslbeck & Wieland (1975) . The low pyruvate dehydrogenase activity in human adipose tissue may be due to species differences or to adaptations to environmental differences, since it is known that the activity of the rat adipose tissue enzyme decreases if the animal's dietary fat content approaches the level seen in human diets (Stansbie et al., ,1976 Goldrick & Galton, 1974 ; Sjostrom, 1973) may be related to the low activity of pyruvate dehydrogenase, which is known to play a major role in the control of fatty acid synthesis de novo in rat adipose tissue.
General conclusions
The human pyruvate dehydrogenase complex is regulated by a phosphorylation-dephosphorylation cycle and the properties of its kinase and phosphatase are essentially similar to those of the other mammalian complexes studied. An understanding of the regulatory features of the human enzyme is an essential prerequisite for the identification of any abnormalities in the control of the complex that may be present in tissues from patients. 
